INBS INTELLIGENT BIO SOLUTIONS INC.
AI brief AI-written, not reviewed by a person
Latest available figures show cash and equivalents of 3,992,312 USD at 2026-06-30, stockholders’ equity of 5,510,835 USD at 2026-06-30, and total assets of 11,941,836 USD at 2026-06-30, with 12-month revenue of 4,215,175 USD and 12-month net loss of 12,430,975 USD. Over the prior year period, 2025-06-30, cash and equivalents were 1,019,909 USD, stockholders’ equity was 2,996,136 USD, total assets were 8,249,786 USD, revenue was 3,052,532 USD, and net loss was 10,568,733 USD, indicating year-over-year changes in liquidity, capitalization, and operating results as reported in the SEC filings. The latest filings include a 10-K/A and a related 8-K in October 2026, updating the historical context and confirming the same-period figures for the prior year as cited.
- Cash and equivalents at 2026-06-30: 3,992,312 USD; 2026-03-31: 6,862,204 USD; 2025-12-31: 740,371 USD; 2025-09-30: 1,660,105 USD; 2025-06-30: 1,019,909 USD. [1][2]
- Diluted EPS (year) 12 months to 2026-06-30: -8.44 USD/shares; 12 months to 2025-06-30: -20.04 USD/shares. [1]
- Diluted EPS (quarter) 3 months to 2026-03-31: -1.8 USD/shares; 3 months to 2025-12-31: -2.82 USD/shares. [1]
- Stockholders' equity at 2026-06-30: 5,510,835 USD; 2026-03-31: 8,961,565 USD; 2025-12-31: 11,093,132 USD; 2025-09-30: 3,621,227 USD; 2025-06-30: 2,996,136 USD. [1]
- Net income (year) 12 months to 2026-06-30: -12,430,975 USD; 12 months to 2025-06-30: -10,568,733 USD. [1]
- Net income (quarter) 3 months to 2026-03-31: -2,862,712 USD; 3 months to 2025-12-31: -2,677,590 USD; 3 months to 2025-09-30: -2,983,006 USD; 3 months to 2025-03-31: -2,543,526 USD; 3 months to 2024-12-31: -2,249,470 USD. [1]
- Operating cash flow (year) 12 months to 2026-06-30: -11,927,222 USD; 12 months to 2025-06-30: -9,677,313 USD. [1]
- Operating cash flow (quarter) 3 months to 2025-09-30: -2,846,825 USD; 3 months to 2024-09-30: -2,387,216 USD; 3 months to 2023-09-30: -1,311,833 USD; 3 months to 2022-09-30: -1,893,735 USD; 3 months to 2021-09-30: 82,962 USD. [1]
- Operating income (year) 12 months to 2026-06-30: -12,608,085 USD; 12 months to 2025-06-30: -10,679,158 USD. [1]
- Operating income (quarter) 3 months to 2026-03-31: -2,947,101 USD; 3 months to 2025-12-31: -2,635,738 USD; 3 months to 2025-09-30: -2,999,593 USD; 3 months to 2025-03-31: -2,560,329 USD; 3 months to 2024-12-31: -2,264,482 USD. [1]
- Revenue (year) 12 months to 2026-06-30: 4,215,175 USD; 12 months to 2025-06-30: 3,052,532 USD. [1]
- Revenue (quarter) 3 months to 2026-03-31: 1,060,802 USD; 3 months to 2025-12-31: 896,774 USD; 3 months to 2025-09-30: 1,111,797 USD; 3 months to 2025-03-31: 728,867 USD; 3 months to 2024-12-31: 607,494 USD. [1]
- Shares outstanding at 2026-08-18: 3,027,470; at 2026-05-12: 2,391,846; at 2026-02-12: 1,603,783; at 2025-11-10: 9,452,553; at 2025-08-12: 8,979,152. [1]
- Total assets at 2026-06-30: 11,941,836 USD; at 2026-03-31: 14,862,792 USD; at 2025-12-31: 17,653,042 USD; at 2025-09-30: 10,038,309 USD; at 2025-06-30: 8,249,786 USD. [1]
- Total liabilities at 2026-06-30: 6,651,010 USD; 2026-03-31: 6,111,476 USD; 2025-12-31: 6,763,231 USD; 2025-09-30: 6,611,380 USD; 2025-06-30: 5,435,962 USD. [1]
- 10-K/A filed 2026-10-21; index page available; update to prior year context. [1]
- 8-K filed 2026-10-13; accompanying materials published; updates to filing context. [1]
Written by OpenVibe.AI from the SEC numbers and filings on this page, not reviewed by a person. Informational only; not investment advice. Written from figures and filings up to (gpt-5-nano-2025-08-07).
Observations
| Metric | Value | Observed | Source | Retrieved | Freshness |
|---|---|---|---|---|---|
| Revenue (quarter) (3 months to 2026-03-31) | 1,060,802 USD | sec-companyfacts | current | ||
| Revenue (year) (12 months to 2026-06-30) | 4,215,175 USD | sec-companyfacts | current | ||
| Net income (quarter) (3 months to 2026-03-31) | -2,862,712 USD | sec-companyfacts | current | ||
| Net income (year) (12 months to 2026-06-30) | -12,430,975 USD | sec-companyfacts | current | ||
| Operating income (quarter) (3 months to 2026-03-31) | -2,947,101 USD | sec-companyfacts | current | ||
| Operating income (year) (12 months to 2026-06-30) | -12,608,085 USD | sec-companyfacts | current | ||
| Diluted EPS (quarter) (3 months to 2026-03-31) | -1.8 USD/shares | sec-companyfacts | current | ||
| Diluted EPS (year) (12 months to 2026-06-30) | -8.44 USD/shares | sec-companyfacts | current | ||
| Operating cash flow (quarter) (3 months to 2025-09-30) | -2,846,825 USD | sec-companyfacts | current | ||
| Operating cash flow (year) (12 months to 2026-06-30) | -11,927,222 USD | sec-companyfacts | current | ||
| Total assets (at 2026-06-30) | 11,941,836 USD | sec-companyfacts | current | ||
| Total liabilities (at 2026-06-30) | 6,651,010 USD | sec-companyfacts | current | ||
| Stockholders' equity (at 2026-06-30) | 5,510,835 USD | sec-companyfacts | current | ||
| Cash and equivalents (at 2026-06-30) | 3,992,312 USD | sec-companyfacts | current | ||
| Shares outstanding (at 2026-08-18) | 3,027,470 shares | sec-companyfacts | current |
Context
No reviewed context has been published for INBS. The observations and documents below are shown as their sources stated them.
Documents
Source freshness
| Source | Freshness | Last successful fetch | Stale after | Sources reports |
|---|---|---|---|---|
| SEC EDGAR: company financial facts (XBRL) sec-companyfacts | current | 10080 min | ok | |
| SEC EDGAR: latest XBRL filings sec-xbrl-filings | current | 45 min | healthy |
Watch this instrument
Sign in to add INBS to a private watchlist or to get an alert when a new document or observation arrives.
Machine-readable: INBS.json (the same data with every timestamp and source).
Information only — not investment advice; no trading here. OpenVibe.Trade holds no money or assets, takes no orders and gives no personal recommendations.